A top clinical panel of experts discuss legal and clinical updates on how clinicians are adapting to those considering the EOLOA. Purpose: enhance care quality and support for patients and families.
Join us for a presentation and discussion of clinical considerations in Medical Aid In Dying.
The End Of Life Option Act signed into law in California in 2016 allows for a physician to prescribe a lethal dose of medication to terminally ill people with a prognosis of 6 months or less who meet stringent eligibility criteria and voluntarily make the request.
Legal in California, as in nine other states plus the District of Columbia, Medical Aid In Dying is now part of end of life care, and yet access to best practice guidelines and clinical updates remains limited.
Our panel discussion brings together clinician experts who work with patients as they consider and enroll in Medical Aid In Dying programs across the East Bay. Learn how clinicians are adapting to working with patients considering medical aid in dying, and how EOLOA programs are being designed to provide quality care and support patients and family as well as clinicians.
1. To gain an overview of current CA End of Life Options Act data, including patient demographics, prescribing patterns, and clinical outcomes
2. To understand clinical considerations regarding patient eligibility, prognostication, and key partnerships with palliative care and hospice
3. To learn how clinicians support patients and families as they consider and enroll in Medical Aid In Dying programs as part of their end of life care planning